Castle Creek Biosciences

Castle Creek Biosciences

Castle Creek Biosciences

Castle Creek Biosciences autologous cell and gene therapies target the underlying causes of diseases affecting the skin and connective tissue.
Type
B2c
Founded
2015
Raised
$75M
Follow us
Alexa global traffic share